These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23487209)
41. [Basis, clinical aspects and therapy of Parkinson's syndrome]. Hofferberth B Krankenpfl J; 1984 Nov; 22(11):15-9. PubMed ID: 6569910 [No Abstract] [Full Text] [Related]
42. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches]. Faludi B; Janszky J; Komoly S; Kovács N Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904 [TBL] [Abstract][Full Text] [Related]
43. [The recent advance of treatment of Parkinson's disease]. Matsubara E Nihon Rinsho; 2004 Sep; 62(9):1725-8. PubMed ID: 15462392 [TBL] [Abstract][Full Text] [Related]
44. Parkinson's disease. Second of two parts. Lang AE; Lozano AM N Engl J Med; 1998 Oct; 339(16):1130-43. PubMed ID: 9770561 [TBL] [Abstract][Full Text] [Related]
45. Parkinson's disease. New treatments, still no cure. Mayo Clin Health Lett; 2001 May; 19(5):1-3. PubMed ID: 11349631 [No Abstract] [Full Text] [Related]
46. Guideline for the treatment of Parkinson's disease. Carr J; Kies B; Fine J; S Afr Med J; 2009 Oct; 99(10):755-6, 758. PubMed ID: 20128276 [No Abstract] [Full Text] [Related]
47. Overview of Parkinson's disease. Lew M Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935 [TBL] [Abstract][Full Text] [Related]
48. Challenges of medication management in hospitalized patients with Parkinson's disease. Wood LD; Neumiller JJ; Carlson J; Setter SM; Corbett CF Am J Health Syst Pharm; 2010 Dec; 67(23):2059-63. PubMed ID: 21098379 [No Abstract] [Full Text] [Related]
49. Levodopa and the progression of Parkinson's disease. Walton-Hadlock JL N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240 [No Abstract] [Full Text] [Related]
50. Parkinson's disease. Clarke CE; Moore AP Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619 [No Abstract] [Full Text] [Related]
51. [Parkinson's diseases: power of search]. Agid Y Rev Neurol (Paris); 2010 Oct; 166(10):755. PubMed ID: 20801469 [No Abstract] [Full Text] [Related]
52. [ What drug strategies are advisable for patients with advanced-stage Parkinson's]. Brefel-Courbon C Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046 [No Abstract] [Full Text] [Related]
55. Open withdrawal of antiparkinson drugs in the neuroleptic- induced Parkinson syndrome. Fleischhauer J Int Pharmacopsychiatry; 1975; 10(4):222-9. PubMed ID: 1240094 [TBL] [Abstract][Full Text] [Related]
56. Painful dystonic spasms in Parkinson's disease. Ilson J; Fahn S; Côté L Adv Neurol; 1984; 40():395-8. PubMed ID: 6695618 [No Abstract] [Full Text] [Related]
58. Novel insights in pharmacogenetics of drug response in Parkinson's disease. Arbouw ME; Guchelaar HJ; Egberts TC Pharmacogenomics; 2010 Feb; 11(2):127-9. PubMed ID: 20136351 [No Abstract] [Full Text] [Related]
59. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437 [TBL] [Abstract][Full Text] [Related]
60. Current approaches in the treatment of Parkinson's disease. Stacy M; Jankovic J Annu Rev Med; 1993; 44():431-40. PubMed ID: 8476262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]